Website News and Research

RSS

T1DM therapeutics market expected to reach $7.1 billion by 2021

Analysis from business intelligence provider GBI Research - Type 1 Diabetes Mellitus Therapeutics in Major Developed Markets to 2021 - states that the global market value for T1DM treatment will rise from $4.2 billion in 2014 to $7.1 billion by 2021, at a robust Compound Annual Growth Rate (CAGR) of 7.9%.

24 Nov 2015

New study finds evidence to support meperidine-associated seizure risk

Meperidine, an opioid analgesic commonly used to control shivering in accidental or therapeutic hypothermia, has been linked to increased seizure risk, but a new study finds little published evidence to support this risk.

24 Nov 2015

Microgravity inhibits regenerative and differentiation potential of embryonic stem cells

A study performed on the NASA Space Shuttle Discovery showed that exposure of mouse embryonic stem cells (mESCs) to microgravity inhibited their ability to differentiate and generate most cell lineages, needed for the development of bone, muscle, the immune system, and other organs and tissues.

24 Nov 2015

Complex numeric data on hospital-acquired infections confuses consumers

Patients have difficulty deciphering complex numeric data on healthcare-associated infections used by the Centers for Medicare and Medicaid Services to help consumers choose hospitals, according to a new study published online today in Infection Control & Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of America (SHEA).

24 Nov 2015

New mathematical model forecasts metastatic breast cancer survival rates

USC researchers have developed a mathematical model to forecast metastatic breast cancer survival rates using techniques usually reserved for weather prediction, financial forecasting and surfing the Web.

24 Nov 2015

Tips to help people living with diabetes survive the holiday season

The holidays are a time to gather with family and friends. It's also a season to indulge in all of your favorite holiday foods and drink. For people living with diabetes, keeping blood sugars under control is often a challenge, but the holiday season can bring additional hurdles.

22 Nov 2015

New study identifies patient-reported barriers to quality end-of-life care among ethnic minorities

A new study identifies six main patient-reported barriers to receiving quality end-of-life (EOL) care among ethnic minority populations. The biggest barrier is lack of sufficient financial resources and insurance, according to the article published in Journal of Palliative Medicine, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.

19 Nov 2015

New article examines women's perceptions of relationship in Fifty Shades of Grey

Examining women's perceptions of the relationship between Christian and Anastasia in the popular movie Fifty Shades of Grey is a safe and valuable way to discuss healthy and unhealthy relationship dynamics, including the warning signs of intimate partner violence. Young women expressed mixed views, describing parts of the movie relationship as exciting and romantic and other aspects as controlling, manipulative, and emotionally abusive in a new study published in Journal of Women's Health, a peer-reviewed publication from Mary Ann Liebert, Inc., publishers.

19 Nov 2015

Coordinated care and telehealth deployment ‘cookbook’ debuted

Royal Philips and its ACT-program consortium partners today announced the debut of a ‘cookbook’ outlining key enablers necessary to scale connected care and telehealth programs.

18 Nov 2015

New NICE-accredited guidelines on prevention and control of MDRGNB available online

Gram-negative bacteria (MDRGNB) include common types such as E. coli that all of us carry in our bowels. When these bacteria get into other parts of the body they can cause infections, including common infections such as cystitis or urinary tract infections. The bacteria can also be readily spread from person to person. Multi-drug-resistant strains are resistant to most, or all, of the common antibiotics that we use to treat infections.

18 Nov 2015

Living with lung cancer: an interview with Aoife McNamara

Understanding how lung cancer affects patients from a social perspective is vital. People living with lung cancer, lung cancer survivors and carers are impacted by lung cancer in different ways.

18 Nov 2015

FixHepC Buyers Club exposes weakness in Australian healthcare, assists patients to import life saving medication

In one of the greatest advances in medicine in decades, Hepatitis C is now largely curable. Over 200,000 Australians suffer from Hepatitis C. However the US manufacturer, Gilead Sciences Inc is attempting to charge the PBS $84,000 for a 12 week course of medication that costs under $200 dollars to manufacture.

13 Nov 2015

Prostate cancer market to expand at CAGR of 9.5% to $13.6 billion by 2021

Analysis from business intelligence provider GBI Research - Prostate Cancer Market to 2021 - Increasing Disease Prevalence to be a Key Driver of Market Growth - says that the prostate cancer market will expand at a rapid Compound Annual Growth Rate (CAGR) of 9.5% from $7.6 billion in 2014 to $13.6 billion by 2021.

12 Nov 2015

UT Southwestern named one of nation's 'Most Connected Hospitals' for 2015-2016

UT Southwestern Medical Center has been ranked one of the "Most Connected Hospitals" for 2015-2016 by U.S. News & World Report based on its commitment to the use of digital technology in health care.

12 Nov 2015

ACR releases 2015 Guideline for Treatment of Rheumatoid Arthritis

The American College of Rheumatology (ACR) released its 2015 Guideline for the Treatment of Rheumatoid Arthritis (RA) during the 2015 ACR/ARHP Annual Meeting in San Francisco.

11 Nov 2015

Anavex reports safety and efficacy data of ANAVEX 2-73 Phase 2a trial in Alzheimer’s patients

On Saturday, investigators presented positive safety and cognitive efficacy data for ANAVEX 2-73, the Company’s lead investigational oral treatment for Alzheimer’s disease targeting sigma-1 and muscarinic receptors, which are believed to reduce protein misfolding including reduction of beta amyloid, tau protein and inflammation at the international CTAD 2015 conference in Barcelona, Spain.

11 Nov 2015

AACR rapid and dramatic responses in TRK fusion patients

Loxo Oncology, Inc., a biopharmaceutical company innovating the development of highly selective medicines for patients with genetically defined cancers, today announced new results from its Phase 1 open-label, dose-escalation trial of LOXO-101, a selective inhibitor of tropomyosin receptor kinase (TRK) signaling molecules, and the first preclinical data for its RET and FGFR programs. The data are being presented at the 2015 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics in Boston.

9 Nov 2015

Agios announces data from dose-escalation phase 1 study of AG-120 in patients with IDH1 mutant positive advanced solid tumors

Agios Pharmaceuticals, Inc., a leader in the fields of cancer metabolism and rare genetic metabolic disorders, today announced the first data from the dose-escalation portion of the ongoing Phase 1 study evaluating single agent AG-120, a first-in-class, oral, selective, potent inhibitor of mutant isocitrate dehydrogenase-1 (IDH1), in advanced solid tumors. The data are being presented today at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics in Boston. AG-120 is being developed in collaboration with Celgene.

9 Nov 2015

Chromatin Immunoprecipitation validated antibodies launched by Chromatrap

Chromatrap, a business unit of Porvair Sciences Ltd, has announced the launch of its own range of Chromatin Immunoprecipitation (ChIP)-validated antibodies.

From Chromatrap® - Porvair Sciences Ltd 9 Nov 2015

PCSG campaign highlights significance of family doctors in early gastroenterological cancer diagnosis

With cancer survival rates in the UK persistently trailing comparable European countries, it’s time to admit to a national problem – and do something about it, says a leading expert at the Primary Care Society for Gastroenterology.

6 Nov 2015

Website News and Research

T1DM therapeutics market expected to reach $7.1 billion by 2021

New study finds evidence to support meperidine-associated seizure risk

Microgravity inhibits regenerative and differentiation potential of embryonic stem cells

Complex numeric data on hospital-acquired infections confuses consumers

New mathematical model forecasts metastatic breast cancer survival rates

Tips to help people living with diabetes survive the holiday season

New study identifies patient-reported barriers to quality end-of-life care among ethnic minorities

New article examines women's perceptions of relationship in Fifty Shades of Grey

Coordinated care and telehealth deployment ‘cookbook’ debuted

New NICE-accredited guidelines on prevention and control of MDRGNB available online

Living with lung cancer: an interview with Aoife McNamara

FixHepC Buyers Club exposes weakness in Australian healthcare, assists patients to import life saving medication

Prostate cancer market to expand at CAGR of 9.5% to $13.6 billion by 2021

UT Southwestern named one of nation's 'Most Connected Hospitals' for 2015-2016

ACR releases 2015 Guideline for Treatment of Rheumatoid Arthritis

Anavex reports safety and efficacy data of ANAVEX 2-73 Phase 2a trial in Alzheimer’s patients

AACR rapid and dramatic responses in TRK fusion patients

Agios announces data from dose-escalation phase 1 study of AG-120 in patients with IDH1 mutant positive advanced solid tumors

Chromatin Immunoprecipitation validated antibodies launched by Chromatrap

PCSG campaign highlights significance of family doctors in early gastroenterological cancer diagnosis

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News